Questions remain about Paxlovid eligibility and use
When the antiviral drug Paxlovid was approved by the Food and Drug Administration in late 2021, many experts hailed it as a game-changing treatment for high-risk patients battling COVID-19.
When the antiviral drug Paxlovid was approved by the Food and Drug Administration in late 2021, many experts hailed it as a game-changing treatment for high-risk patients battling COVID-19.